Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2022 | Topics and themes of interest at ESMO 2022

Matthew Gitlin • 31 Aug 2022
ESMO 2022
General CAR-T

Matthew Gitlin, PharmD, BluePath Solutions, Los Angeles, CA, highlights topics of interest that will be presented at the European Society for Medical Oncology (ESMO) 2022 Congress, including novel technologies such as gene therapies and chimeric antigen receptor (CAR) T-cell therapy, which will play an increasing role in treatment of various cancers. This interview took place at the ESMO 2022 Congress in Paris, France.

More from Matthew Gitlin

3:58
Comparing time to diagnosis for different cancers in the USA
Matthew Gitlin • 31 Aug 2022
1:20
Facilitating the decision making process in healthcare research
Matthew Gitlin • 31 Aug 2022
2:23
Strategies to improve time to diagnosis in patients with cancer
Matthew Gitlin • 31 Aug 2022

Related Videos

2:03
Biomarker detection for early cancer detection
Robert Rintoul • 19 Apr 2024
0:29
Innovative ctDNA-based liquid biopsy techniques for cancer diagnosis
Alain Thierry • 9 Apr 2024
0:50
Employing fragmentomics as a novel strategy to characterize and detect cancers
Alain Thierry • 9 Apr 2024
1:27
Emerging trials in melanoma: SWOG S1801, OpACIN-neo and PRADO
Christoffer Gebhardt • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals